Chief Medical Officer

Spyre Therapeutics Completes $316 Million Public Offering

Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.2 Million

Spyre Therapeutics Closes $316.2 Million Public Offering

Spyre Therapeutics Launches Public Offering

Senior Manager, Medical Writer

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing innovative products for inflammatory bowel disease and other immune-mediated diseases. The Senior Manager, Medical Writer will lead the medical writing strategy and be responsible for authoring and managing clinical and regulatory documents while collaborating with cross-functional teams to ensure compliance with regulatory standards.

Sign up with Google

Sign in with Google